Time To Buy The Dip In Oscar Health Stock?
Oscar Health (OSCR) stock has fallen by 11.6% in less than a month, from $15.05 on 4th Mar, 2026 to $13.30 now. Should you buy this dip?
Dip buying is a viable strategy for quality stocks that have a history of recovering from dips. As it turns out, OSCR stock passes basic quality checks. Historically, the median return for the 12-month period following sharp dips was 3.3% , with median peak return reaching 41%. We define sharp dip as stock going down 20% or more, in less than 30 day period.
Below, we get into details of historical dips and subsequent returns.
Historical Median Returns Post Dips
- Could Cash Machine Abbott Laboratories Stock Be Your Next Buy?
- Pay Less, Gain More: CLS, APH Top Flex Stock
- Stronger Bet Than IDEXX Laboratories Stock: DXCM, BSX Deliver More
- MU, FSLR Top ON Semiconductor Stock on Price & Potential
- EQT Looks Smarter Buy Than ConocoPhillips Stock
- Better Value & Growth: OKE Leads Cheniere Energy Stock
| Period | Past Median Return |
|---|---|
| 1M | -2.4% |
| 3M | -7.1% |
| 6M | -9.0% |
| 12M | 3.3% |
Historical Dip-Wise Details
OSCR had 15 events since 1/1/2010 where the dip threshold of -20% within 30 days was triggered
- 41% median peak return within 1 year of dip event
- 84 days is the median time to peak return after a dip event
- -27% median max drawdown within 1 year of dip event
| 30 Day Dip | OSCR Subsequent Performance | |||||||
|---|---|---|---|---|---|---|---|---|
| Date | OSCR | SPY | 1Y | Peak Return |
Max Drop |
# Days to Peak |
||
| Median | 3% | 41% | -27% | 84 | ||||
| 2232026 | -26% | -1% | 7% | 21% | -1% | 9 | ||
| 11102025 | -24% | 3% | -9% | 24% | -16% | 16 | ||
| 8012025 | -28% | 4% | -2% | 65% | -10% | 67 | ||
| 3132025 | -23% | -8% | 3% | 74% | -10% | 208 | ||
| 12162024 | -21% | 6% | 8% | 62% | -17% | 295 | ||
| 10232024 | -23% | 5% | 23% | 41% | -27% | 349 | ||
| 6272024 | -23% | 5% | 16% | 32% | -34% | 84 | ||
| 3252024 | -24% | 4% | -0% | 72% | -5% | 57 | ||
| 7312023 | -21% | 4% | 135% | 210% | -36% | 295 | ||
| 3272023 | -27% | -2% | 296% | 408% | 0% | 325 | ||
| 9222022 | -22% | -11% | 10% | 90% | -58% | 264 | ||
| 5052022 | -24% | -7% | 2% | 8% | -71% | 102 | ||
| 11112021 | -28% | 8% | -76% | 0% | -81% | 0 | ||
| 7122021 | -21% | 5% | -76% | 6% | -79% | 9 | ||
| 4152021 | -28% | 9% | -64% | 16% | -77% | 53 | ||
Oscar Health Passes Basic Financial Quality Checks
Revenue growth, profitability, cash flow, and balance sheet strength need to be evaluated to reduce the risk of a dip being the sign of a deteriorating business situation.
| Quality Metrics | Value | Quality Check |
|---|---|---|
| Revenue Growth (LTM) | 27.5% | Pass |
| Revenue Growth (3-Yr Avg) | 42.1% | Pass |
| Operating Cash Flow Margin (LTM) | 9.4% | Pass |
| Leverage (see below) | – | Pass |
| => Interest Coverage Ratio | -23.8 | |
| => Cash To Interest Expense Ratio | 226.7 |
Not sure if you can take a call on OSCR stock? Consider portfolio approach
Portfolios Are The Smarter Way To Invest
Single stocks swing wildly but staying invested matters. A well built portfolio helps you stay invested, captures upside and softens the blows from individual stocks.
Beating the market consistently is hard, but the Trefis High Quality (HQ) Portfolio makes it look achievable. By selecting 30 high-conviction stocks, the HQ strategy has historically outpaced the S&P 500, S&P Mid-cap, and Russell 2000. See how this curated selection delivers superior risk-adjusted returns in our detailed performance factsheet.